granted
on 28 Aug 2024
Last Applicant/ Owned by
401 N. Broad St.
Philadelphia
PA
19108
Serial Number
97227503 filed on 19th Jan 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic Read More
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
N/A
N/A
No 97227503
No Service Mark
No 4736/2005
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
28th Aug 2024 | SOU EXTENSION 3 FILED |
28th Aug 2024 | SOU EXTENSION 3 GRANTED |
28th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
28th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
06th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
05th Mar 2024 | SOU EXTENSION 2 FILED |
05th Mar 2024 | SOU EXTENSION 2 GRANTED |
05th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
28th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
26th Jul 2023 | SOU EXTENSION 1 GRANTED |